Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan

Benedikte Hasselbalch, Jesper Grau Eriksen, Helle Broholm, Ib Jarle Christensen, Kirsten Grunnet, Michael Robert Horsman, Hans Skovgaard Poulsen, Marie-Thérése Stockhausen, Ulrik Lassen

    38 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan'. Together they form a unique fingerprint.

    Medicine & Life Sciences